Early Diagnostics in Cancer Therapy
Quantum Biosciences is pioneering a quantum sensing platform to detect cellular injury from treatments like radiation therapy hours after exposure—not months or years later when the damage is irreversible. Our mission is to provide the real-time, molecular-level insights that enable proactive, personalized patient care.
From Cellular Stress to Predictive Score
The Quantum Sentinel™ platform is our integrated solution for predictive toxicology. We've engineered a workflow that gives clinicians a 'biological test drive' of their treatment plan, translating the earliest molecular whispers of cellular stress into a clear, actionable risk score. Here's how it works:
1. Detect the Earliest Molecular Signals
Our platform uses proprietary NV-diamond quantum sensors to detect the earliest warning signs of cellular injury—the burst of Reactive Oxygen Species (ROS)—from a patient's blood sample.
1. Detect the Earliest Molecular Signals
Our platform uses proprietary NV-diamond quantum sensors to detect the earliest warning signs of cellular injury—the burst of Reactive Oxygen Species (ROS)—from a patient's blood sample.
2. Decode the Signal with AI
Our core advantage is our in-silico engine and patented AI, which is trained on a vast library of "magnetic fingerprints." This computational work, an evolution of our original Digital Twin research, allows us to simulate cellular responses and translate noisy quantum data from the sensor into a clear, predictive clinical insight.
2. Decode the Signal with AI
Our core advantage is our in-silico engine and patented AI, which is trained on a vast library of "magnetic fingerprints." This computational work, an evolution of our original Digital Twin research, allows us to simulate cellular responses and translate noisy quantum data from the sensor into a clear, predictive clinical insight.
3. Deliver a Predictive Risk Score
The result is an "Ex-vivo Radiosensitivity Index"—a personalized risk score that empowers clinicians to tailor therapy and protect patients from long-term harm. This is the future of proactive, personalized oncology.
3. Deliver a Predictive Risk Score
The result is an "Ex-vivo Radiosensitivity Index"—a personalized risk score that empowers clinicians to tailor therapy and protect patients from long-term harm. This is the future of proactive, personalized oncology.
The Quantum Biosciences Advantage
We are uniquely positioned to drive breakthroughs at the convergence of quantum science and biology. Here's how:
Synergistic Innovation
Our core strength lies in uniquely fusing deep quantum physics expertise with advanced biological and medical science, creating novel solutions unachievable by a single discipline.
Collaborative Impact
We cultivate a dynamic ecosystem of world-class academic institutions, industry leaders, and clinical experts to accelerate research and translate discoveries into real-world applications.
Vision for Tomorrow
We are dedicated to building foundational technologies and insights that will redefine the future of health and science, tackling complex global challenges with a long-term perspective.
Collaborate With Us: Let's Shape the Future Together
Quantum Biosciences is actively seeking passionate researchers, visionary clinicians, innovative industry partners, and driven individuals to join us in our mission. If you are excited by the prospect of working at the cutting edge of quantum technologies and biosciences to create a healthier future, we want to hear from you.